Download Issue.pdf

The 2017 Outsourcing Resources supplement to the March 2017 issue of PharmTech Europe features articles on insourcing vs outsourcing, outsourced on-site audits, raw materials testing, quality agreements, serialization, and identification of medicinal products. The issue editor is Adeline Siew, and the supplement covers various aspects of pharmaceutical outsourcing, including the challenges of IDMP compliance and the final countdown to serialization. The publication also includes a guide to conventional and biotech pharmaceutical outsourcing services and an ad index.

The supplement discusses the importance of aseptic manufacturing in drug development and commercialization, and how leading global bio/pharmaceutical firms are rethinking their business models due to expiring patents, tighter regulatory requirements, and increased competition. Small biotech companies often lack the resources to perform in-house development and manufacturing, making outsourcing a more viable option. Medium-sized companies also tend to outsource, despite having the financial depth to build up the needed expertise, as they focus their resources on R&D and marketing.